Endovascular treatment of upper limb phlegmasia cerulea dolens in a hemodialysis patient

Nikolaos Galanakis,Nikolaos Kontopodis,Dimitrios Xydakis,Eleni Tzali,Dimitrios Tsetis,Elias Kehagias
DOI: https://doi.org/10.1177/11297298241301509
2024-12-04
The Journal of Vascular Access
Abstract:The Journal of Vascular Access, Ahead of Print. Phlegmasia cerulea dolens (PCD) is a rare but limb-threatening complication of deep vein thrombosis. A 72-year-old hemodialysis male patient presented with upper limb PCD. The patient underwent hemodialysis via a permanent hemodialysis central venous catheter (HD-CVC) while a new brachial-cephalic AVF was created 1 month ago. Computed tomography revealed extensive thrombosis of right subclavian and brachiocephalic vein. The HD-CVC was removed and patient was treated with anticoagulation therapy. However, his clinical condition was worsening and he was transferred to IR department. The patient underwent successful percutaneous pharmacomechanical thrombectomy (PMT) of the right subclavian and brachiocephalic vein followed by percutaneous angioplasty (PTA) with significant flow restoration and no signs of pulmonary embolization. PCD may also be developed in hemodialysis patients with well-functioned AVF. Effective and rapid revascularization is important to prevent serious complications such as venous gangrene and limb ischemia. Endovascular treatment with PMT and PTA can be a limb-saving procedure for rapid recanalization in patients with PCD.
peripheral vascular disease
What problem does this paper attempt to address?